Study of Sitravatinib With or Without Other Anticancer Therapies Receiving Clinical Benefit From Parent Study
Clinical trial NCT04887870 · COMPLETED
Trial details
- NCT number
- NCT04887870
- Sponsor
- Mirati Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-29
- Primary completion
- 2025-04-21
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.